![Pharmacology / Pharmaceutical industry / Pharmaceutical sciences / Organofluorides / Selective serotonin reuptake inhibitors / Abbreviated New Drug Application / Generic drug / Paroxetine / Antidepressant / Chemistry / Organic chemistry / Pharmaceuticals policy Pharmacology / Pharmaceutical industry / Pharmaceutical sciences / Organofluorides / Selective serotonin reuptake inhibitors / Abbreviated New Drug Application / Generic drug / Paroxetine / Antidepressant / Chemistry / Organic chemistry / Pharmaceuticals policy](https://www.pdfsearch.io/img/4b6d0068d73efec43113cb111a21c3c9.jpg)
| Document Date: 2013-01-18 14:32:50 Open Document File Size: 800,67 KBShare Result on Facebook
City Ottawa / / Country Canada / / / Event Diplomatic Relations / / Facility Canadian Institute / / / IndustryTerm substitute product / generic drug product / drug product / prescription drug products / pharmaceutical trends / pharmaceutical market / drug products / pmprb@pmprb-cepmb.gc.ca Web / overall pharmaceutical market / / NaturalFeature Edward Island / / Organization Patented Medicine Prices Review Board / NPDUIS Steering Committee / Canadian Institute for Health Information / / Person Paroxetine (Paxil) Gabapentin / Pravastatin (Pravacol) Citalopram / Drug Omeprazole (Losec) / Citalopram (Celexa) Paroxetine / / / Position Executive Summary Introduction General / physician / Minister of Health / General / Contents Executive / / Product Celexa / Neurontin / simvastatin / gabapentin / risperidone / Paxil / omeprazole / Zocor / / ProvinceOrState Alberta / New Brunswick / Saskatchewan / Manitoba / Prince Edward Island / Nova Scotia / British Columbia / Ontario / / Technology PDF / / URL www.pmprb-cepmb.gc.ca / /
SocialTag |